Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2019.05.007
PubMed Identifier: 31200322
Publication URI: http://europepmc.org/abstract/MED/31200322
Type: Journal Article/Review
Volume: 116
Parent Publication: European journal of cancer (Oxford, England : 1990)
ISSN: 0959-8049